Systematic development of predictive mathematical models for animal cell cultures by Kontoravdi, C et al.
 1 
Systematic development of predictive mathematical models for animal cell 
cultures 
 
Cleo Kontoravdi
1
, Efstratios N. Pistikopoulos
1
 and Athanasios Mantalaris
1,* 
 
 
1
Biological Systems Engineering Laboratory, Centre for Process Systems Engineering, 
Department of Chemical Engineering, Imperial College London, South Kensington Campus, 
London SW7 2AZ, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Corresponding Author 
Biological Systems Engineering Laboratory 
Centre for Process Systems Engineering 
Department of Chemical Engineering 
Imperial College London 
South Kensington campus 
London SW7 2AZ 
Phone: +44(0)2075945601 
Fax: +44(0)2075945638 
Email: a.mantalaris@imperial.ac.uk 
 2 
ABSTRACT 
 
Fed-batch cultures are used in producing monoclonal antibodies industrially. Existing 
protocols are developed empirically. Model-based tools aiming to improve productivity are 
useful with model reliability and computational demand being important. Herein, a systematic 
framework for developing predictive models is presented comprising of model development, 
global sensitivity analysis, optimal experimental design for parameter estimation, and 
predictive capability checking. Its efficacy and validity are demonstrated using a fed-batch 
structured/unstructured model of antibody-secreting hybridoma cultures. Global sensitivity 
analysis is first used to identify sensitive model parameters (initial values estimated from 
batch cultures). Information-rich data from an optimally designed fed-batch experiment are 
then used to estimate these parameters, resulting in good agreement between simulation and 
experimental results. Finally, the model’s predictive capability is confirmed by comparison 
with an independent set of fed-batch cultures. This approach systematises the process of 
developing predictive cell culture models at a minimum experimental cost, enabling model-
based control and optimisation. 
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1. INTRODUCTION 
 
Increasing demand for monoclonal antibodies (MAbs), where time to market becomes 
critical, could benefit from the use of model-based techniques with the aim of optimising and 
controlling cell viability and productivity. The development of reliable mathematical models 
of animal cell cultures is, of course, critical for such applications. In general, these models can 
be classified as either structured or unstructured (Bibila and Robinson, 1995). Unstructured 
models do not take into account the inner structure of the cell, while structured models 
incorporate biological knowledge by lumping the biomaterial into distinct compartments 
(Sidoli et al., 2004). Even though structured models constitute a more detailed and 
biologically consistent representation of cellular activities, they examine single cells and fail 
to describe the collective behaviour of the entire population. Attempts to overcome this 
limitation, including the combination of such single-cell models with population balance 
equations (Sidoli et al., 2006) or simulation of a large number of single-cell models with 
different initial conditions (Domach and Shuler, 1984), pose significant computational and 
validation challenges that render them unsuitable for further application. 
 
Unstructured models, on the other hand, have been proposed as an appropriate basis for 
applying control, optimization and process development techniques to the production process 
of proteins (Dowd et al., 1999; Dhir et al., 2000)). Their main advantages are that they 
involve extracellular culture variables that are typically monitored during a culture, as well as 
that their simulation and subsequent in silico applications are computationally tractable. One 
of the major problems associated with unstructured models though is their limited 
applicability to the process conditions and data range they are derived from. However, it has 
been put forward that the growth of a cell line follows the same kinetics, irrespective of the 
cultivation mode (Pörtner and Schäfer, 1996). It is, therefore, possible that an unstructured 
model developed from batch culture data can also describe fed-batch cultures, which are 
known to increase levels of protein production and are preferred industrially, as long as it is 
properly validated. 
 
For structurally correct models, validation pertains to successful parameter estimation. In the 
case of cell culture models, estimation is usually carried out for all model parameters and 
using already existing (most often, batch) data. Nevertheless, not all parameters may be 
identifiable or estimable, hence the need for an identifiability analysis, or, in the case of 
dynamic, nonlinear models, a sensitivity analysis. The latter studies how a variation in the 
model output can be apportioned to the variation of the different parameters. It is therefore 
used to assess which reduced set of parameters needs to be estimated from experimental data 
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in order to increase model precision. However, unique estimation of the parameter set is only 
possible if the available data are sufficiently rich (Versyck et al., 1997). The use of optimal 
experimental design for estimation of the values of ‘sensitive’ parameters can result in 
significant improvements in parameter confidences (Versyck et al., 1997; Nathanson and 
Saidel, 1985; Munack and Posten, 1989). Optimal experimental design targets the 
determination of input profiles that generate informative experimental data, which then enable 
accurate parameter estimation (Munack, 1989; Munack and Posten, 1989). Optimal 
experimental design can therefore aid the development of a predictive model applicable to a 
wider range of culture conditions through the design of highly dynamic fed-batch 
experiments. Hence, it is proposed to employ these model-based tools in order to systematise 
the methodology for developing predictive mathematical models of protein-producing animal 
cell cultures. The framework put forward and validated herein consists of four steps, namely 
model development, global sensitivity analysis, optimal experimental design for parameter 
estimation, and predictive capability checking, as outlined in Figure 1. 
 
In a previous study (Kontoravdi et al., 2005), a hybrid model of antibody-producing 
mammalian cell cultures was presented and compared to experimental data for the hybridoma 
14-4-4S cell line (Tatiraju et al., 1999). The model is based on the assumption that cell growth 
depends on the availability of two key nutrients, glucose and glutamine, and the accumulation 
of two toxic metabolites, lactate and ammonia. Cell death depends on the accumulation of 
ammonia due to glutamine metabolism and spontaneous degradation in the medium. The 
synthesis of IgG1 antibody product is described starting from the gene copy number and 
synthesis of heavy- and light-chain mRNA molecules. These are then translated into heavy 
and light antibody chains, which sequentially combine to form the antibody molecule (two 
heavy and two light chains) in the endoplasmic reticulum. This molecule then travels to the 
Golgi apparatus and is finally secreted into the extracellular medium. The model equations 
are listed in appendix A and consist of 28 differential and algebraic equations containing 30 
parameters. In summary, the model describes cell growth and antibody synthesis and 
production in the context of laboratory-scale cell cultures. The Sobol´ method of global 
sensitivity analysis was used to identify the model parameters to which the model output 
(MAb concentration) was most sensitive, prompting the need for their accurate estimation 
from experimental data. 
 
In this work, optimal experimental design tools are applied to the aforementioned model in 
order to successfully estimate the values of the ‘sensitive’ parameters and extend the range of 
the model’s validity to fed-batch conditions. First, a supplementary one-at-a-time screening of 
parameter properties with respect to all measured variables was carried out to identify the 
 5 
targets of the parameter estimation and experimental design, thus complementing the previous 
global sensitivity analysis. Batch culture experiments of IgG1-secreting hybridoma cells were 
then performed to provide initial estimates for those parameters, since parameter values 
relating to cell growth and product synthesis and secretion are cell line-specific. Following 
that, D-optimal dynamic experiments were designed to improve parameter accuracy and the 
validity of the resulting model under fed-batch conditions was confirmed by comparison to an 
independent set of fed-batch culture data. To our knowledge, this is one of the first attempts 
to formalise the model development process for cell culture systems, coupling 
experimentation and model-based tools at each step.  
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2. MATERIALS AND METHODS 
 
Hybridoma cell line HFN7.1 producing IgG1 against fibronectin from human plasma (CRL-
1606 from ATCC) was cultured in high-glucose (4.5g/L) DMEM (Gibco) supplemented with 
2.5% bovine calf serum (ATCC). Additional glucose and glutamine required for the fed-batch 
cultures were obtained from Sigma-Aldrich. Both batch and fed-batch cultures were 
conducted in 1L Erlenmeyer flasks with a working volume of 200ml and inoculation cell 
density of 2108cells/L. Temperature and CO2 air concentration were automatically 
controlled at 37
o
C and 5%, respectively. Cell density was measured using a hemacytometer, 
where cell viability was determined by the method of Trypan Blue dye exclusion. For 
determination of nutrient, metabolite and antibody concentration in the culture supernatant, 
1.5 mL samples were withdrawn from the culture, the cells centrifuged at 10
4
g for 5 minutes 
in an Eppendorf microfuge, and the supernatants stored at -20 
o
C. Extracellular glucose, 
glutamine, lactate and ammonia concentrations were measured with the YSI Bioprofiler 200 
(Nova Biomedical, U.K.).  
 
Antibody concentration in the supernatant was estimated by indirect sandwich enzyme-linked 
immunosorbent assay (ELISA).  Specifically, non-cell culture treated 96-well plates (Sigma, 
UK) were coated with 100 L of 1 g/ml anti-human fibronectin antibody from rabbit 
(Sigma) in coating buffer (0.05 M sodium bicarbonate, pH 9.6) after an overnight incubation 
at 4 
o
C.  The plates were blocked for non-specific binding with 250 L/well of blocking 
buffer (250 ml coating buffer with 1.25 g cassein hammerstein; Sigma) for 1 hr at room 
temperature. The plates were washed with washing buffer (phosphate buffered saline with 
0.05% Tween). Subsequently, 100 L of the sample or the control (1mg/ml human 
fibronectin diluted in PBS at a ratio of 1:5,000; Chemicon, UK) were added per well and 
incubated for 1 hr on an orbital plate shaker at room temperature. The plates were washed as 
before followed by addition of 100 L/well of mouse anti-human fibronectin antibody from 
mouse (Sigma) diluted in PBS at a ratio of 1:5,000 and incubated for 2 hrs at room 
temperature on an orbital plate shaker. The plates were washed as before and 100 L of 6.4 
mg/ml anti-mouse Fc antibody from goat (Sigma) diluted in PBS at a ratio of 1:10,000 and 
incubated for 1 hr at room temperature on an orbital plate shaker. Subsequently, the plates 
were washed followed by visualisation of the reaction using the 3,3',5,5'-tetramethylbenzene 
kit (TMB; Sigma-Aldrich T3405) as per the manufacturer’s instructions. The absorbance was 
read at 450 nm on a microplate reader (BioTek Instruments, Inc., USA). 
 
Batch cultures were carried out in triplicate flasks using the aforementioned DMEM medium, 
which corresponds to initial concentrations of 29.1mM for glucose and 4.9mM for glutamine, 
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and 2.5% bovine calf serum. Fed-batch cultures were carried out in duplicate flasks using two 
different sets of initial concentrations. In the first fed-batch culture experiment used for model 
validation, the initial concentration of glucose was 25.1mM and of glutamine 5.01mM. In the 
second, independent experiment, the initial concentration of glucose was 18.4mM and of 
glutamine 3.74mM. The same concentrated medium was supplied to both sets of fed-batch 
cultures in pulses and the concentrations of glucose and glutamine in the feed were set at 
500mM and 100mM, respectively. The maximum total volume of feed was fixed at 8.75ml, 
which represents less than 5% of the total culture volume (200ml), so as to avoid dilution 
effects. 
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3. MODEL DEVELOPMENT PLATFORM 
 
3.1 Model analysis 
The Sobol’ method of global sensitivity analysis was employed to quantitatively assess the 
effect of variation in model parameter values on model output, in this case MAb 
concentration. This is a variance-based Monte-Carlo method that examines the entire range of 
parameter values based on the ANOVA (Analysis of Variances) decomposition of a given 
function into summands of increasing dimensionality (Sobol’, 2001). A further brief one-at-
at-a-time screening of model parameters was carried out for evaluating to which parameters 
the remaining experimentally-measured outputs are sensitive. Hence, the effect of all 
parameters on viable and total cell concentrations was investigated based on model 
simulation.  
 
The global sensitivity analysis identified 8 parameters to which MAb concentration was most 
sensitive (Kontoravdi et al., 2005). A further one-at-a-time screening was performed to 
determine the parameters by which the measured variables were most influenced, since a full 
map of sensitivity indices with respect to all measurements was not available. Those were 
found to be the yield of cells on glucose (Yx,glc), the yield of cells on glutamine (Yx,gln), the 
yield of lactate on glucose (Ylac,glc), the yield of ammonia on glutamine (Yamm,gln), the rate of 
dead cell lysis (Klysis), the maximum specific cell growth rate (μmax), and the gene copy 
number of MAb heavy chains (NH). These parameters were targeted for the parameter 
estimation process, whereas certain parameters identified through the global sensitivity 
analysis study were set at their nominal values as they involved intracellular measurement or 
cell cycle analysis that were not carried out in this study. 
 
Batch culture experiments were initially carried out, through which the validity of the model 
structure to the HFN7.1 hybridoma cell line was confirmed (simulations were carried out 
using gPROMS (PSE, 2002a)). As shown in Figure 2, the model captures the trend of viable 
cell concentration during the initial lag phase and correctly predicts the height and time of the 
peak in the number of viable cells. Model results predict higher concentrations during the 
exponential growth phase, but the overall experimental trend is observed. Similarly, during 
the decline of the viable cell concentration the model correctly captures the shape of the 
concentration profile and, in most cases, provides an accurate prediction of the viable cell 
number. Moreover, MAb concentration is accurately predicted throughout the duration of the 
culture (Figure 2). Similar agreement was achieved for glutamine and ammonia (Figure 3), 
and glucose and lactate (Figure 4).  
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3.2 Optimal experimental design and parameter estimation 
The accurate estimation of the aforementioned 7 parameters under fed-batch conditions was 
the aim of the optimal experimental design, which was conducted using the initial estimates 
as determined from the batch culture data (Table 1). D-optimal experimental design was 
used to maximise the information content of experimental data, specifically for the 
estimation of the seven parameters identified in the sensitivity analysis and one-at-a-
time screening. This is done by minimising the volume of the confidence ellipsoid, 
i.e., minimising the determinant of the variance-covariance matrix, V, of the 
parameters to be estimated.  
 
The optimisation problem seeks to determine the initial conditions, experiment 
duration, variation of controls and timing of samples such that the maximum amount 
of information is generated with the given measurements. These measurements were 
nutrient and metabolite concentrations, the viable and total cell concentrations and the 
extracellular MAb concentration. The design was conducted in the gPROMS (PSE, 
2002b) modelling environment, which has a dedicated function, namely ‘experiment 
design for parameter precision’, and uses a SRQPD sequential quadratic programming 
code. The amount of feed, feeding interval, and experiment duration were treated as 
degrees of freedom within certain operational limits. The initial glucose concentration 
was limited between 5.5 and 25mM. The feed was allowed to vary between 0 and 
12.5ml per hour. Concentrated medium was supplied to the culture vessel in pulses and the 
maximum total volume of feed was fixed at 8.75ml, which represented less than 5% of the 
total culture volume (200ml), so as to avoid dilution effects. The amount of feed supplied at 
each feeding interval was optimised by the design, as was the timing of these intervals. The 
earliest measurement time was set at 12 hours and the minimum time between 
measurements at 6 hours. The duration of the experiment was allowed to vary 
between 4 and 8 days. The optimal duration was determined at 168 hours (7 days), during 
which a pulse feed was introduced once a day, at an interval of 24 hours.  
 
The sequence of designing an experiment, performing it, and using the generated data for 
model validation is done iteratively, until model predictions and experimental data are in 
satisfactory agreement. The results of the designed experiments were used to estimate 
the values of model parameters using the ‘parameter estimation’ entity in gPROMS 
based on the same SRQPD sequential quadratic programming code. Parameter 
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estimation was based on the maximum likelihood formulation, which attempts to 
determine values for the uncertain physical and variance model parameters that 
maximise the probability that the model will predict the measurement values obtained 
from the experiments.  The statistical variance model of constant variance was used in 
this case. In this case, the validation process was successful after one fed-batch experiment 
as the 95% confidence intervals were deemed satisfactory at ±10% of the final parameter 
values. 
 
The complete set of parameter values for fed-batch cultures can be seen in Table 1, where 
they are compared to the corresponding values for batch culture operation. The major 
differences are in the parameters describing nutrient utilisation, as expected. Increased uptake 
of both nutrients in fed-batch culture also results in prolonged cell growth and higher viable 
(and hence, total) cell concentration, and is reflected in the higher values in cell yield on 
glucose and glutamine (2.6x10
8
 and 8x10
8
, respectively) compared to values for batch culture 
(1.1x10
8
 and 5.6x10
8
, respectively). The yield of lactate on glucose is at its maximum value 
of 2 in the case of fed-batch culture, while it is 1.4 in batch culture. This is due to the 
increased availability and utilisation of glucose, which leads to higher conversion into lactate, 
and agrees with previous experimental observations (Glacken et al., 1986; Miller et al., 1988). 
Finally, there is some difference in the values of the heavy and light chain gene copy number. 
As the values for batch cultures represent initial estimates, these are estimated using the data 
for fed-batch operation. The estimated value of 100 genes per cell for both the heavy and the 
light chain is therefore considered to be the most accurate estimate since these figures should 
be independent of culture operation mode. 
 
The results of the parameter estimation and the uncertainty in parameter values expressed in 
confidence intervals are shown in Table 2. The confidence intervals of the estimated 
parameters are satisfactory, with the 95% confidence intervals falling within ±10% of the 
final value for all parameters except Yamm,gln (±17%). The resulting model is in good 
agreement with the results of this first experiment (Figures 5 to 7). More specifically, 
predictions and experimental data for viable and total cell concentrations can be seen in 
Figure 5. Simulation results for viable cell concentration closely match the data during the 
first 60 hours. Thereafter, model predictions follow the trend of the experimental data 
correctly predicting the plateau in viable cell concentration. Over the last 40 hours the model 
over-predicts the concentration of viable cells in the culture. This is probably because the 
viable cell concentration in vitro is too low for the cells to recover viability, but the model 
predicts that will occur as more concentrated feed is supplied to the culture. The data for total 
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cell concentration are more accurately matched by the simulation results (Figure 5). Again, 
there is good agreement over the first 100 hours, with few discrepancies thereafter. The 
overall trend of the concentration is correctly captured by the model. 
 
Figure 6 shows good agreement between model simulation results and experimental data for 
glutamine and ammonia. Glutamine concentration is correctly predicted throughout the 
duration of the culture. Discrepancies only occur once glutamine has reached zero 
concentration (after 80 hours), when additional glutamine fed to the culture is metabolised 
more quickly than predicted. Ammonia concentration is also closely tracked by model results. 
It is correctly predicted during the initial lag phase, over-predicted over the following 70 
hours, and closely matched during the remainder of the culture. Finally, model simulation 
results for extracellular MAb concentration are in good agreement with experimental data as 
shown in Figure 7. The model closely tracks the data throughout the duration of the culture, 
correctly predicting the MAb concentration during the lag and exponential growth phases, as 
well as the final concentration in the medium. Overall, the model captures the profiles of all 
measure variables successfully. 
 
3.3 Predictive capability demonstration 
In order to demonstrate the model's predictive capability, its simulation results were compared 
with an independent set of data from a fed-batch experiment. The initial glucose and 
glutamine concentrations were lower than in the designed experiment and the same amount of 
concentrated feed was introduced in two instead of one dose per day (once every 12 hours). 
The sampling schedule was the same as in the designed experiment, with viable and total cell, 
nutrient, metabolite, and extracellular MAb concentrations determined at each point. 
Glutamine and ammonia concentrations are accurately predicted by the model as shown in 
Figure 8. Simulation results closely track the experimental data for glutamine, with some 
discrepancies between 60 and 90 hours, when the predictions are marginally lower than the 
experimental values. Ammonia concentration data are also matched by model results. There 
are some small discrepancies between 20 and 70 hours, when the predicted concentration is 
higher than observed, and during the final few hours of the culture, when the concentration is 
marginally under-predicted. 
 
In terms of the cell concentrations, the trends of both viable and total cell profiles are 
predicted satisfactorily. The model closely tracks the data for viable cell concentration during 
the first 70 hours of the culture, correctly predicting the lag and exponential growth phases 
(Figure 9). The in silico peak in concentration is lower than the in vitro, but subsequent 
predictions match the data. As in the case of the designed fed-batch experiment, there are 
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discrepancies in the final few hours of the culture, when the model predicts that the cells can 
recover their viability since more nutrients are supplied, but that is not observed 
experimentally. The total cell concentration is correctly predicted throughout the culture. 
There is good agreement between simulation results and experimental data during the lag and 
exponential growth phases. The peak in concentration is then predicted to be higher than that 
observed, after which the decline in cell number is closely tracked by the model. Finally, the 
final extracellular concentration of monoclonal antibodies is correctly estimated by the model 
(Figure 10). This concentration rises more sharply than calculated by the model during the 
exponential growth phase, however, the final concentration achieved is successfully 
calculated. 
 
Overall, based on the level of biological information that is described by the existing model 
structure, the agreement between simulation results and experimental data from the 
independent fed-batch experiment is satisfactory. Previous applications of optimal 
experimental design in this field were restricted to simpler systems of microorganisms 
(Bernaerts et al., 2000) and were often incomplete, as parameter estimation was performed 
using simulated results (Versyck et al., 1997). To our knowledge, this is one of the first 
attempts to close the loop between model-based tools and designed experimentation in 
biological systems and to formalise the steps of the model development process for animal 
cell cultures, avoiding trial-and-error practices and, thus, unnecessary experimentation. The 
resulting model, which was developed at a minimum experimental cost, can be used for in 
silico experimentation, as well as model-based control and optimisation studies. 
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CONCLUDING REMARKS 
A systematic framework for model analysis and experimental design was presented, which 
was used to improve the reliability of a simple, hybrid model of animal cell cultures and to 
extend its range of applicability from batch to fed-batch culture conditions. Overall, the 
framework presented and validated here proposes a well-defined step-by-step methodology 
for building predictive models of cell culture processes at a minimum experimental cost, 
while avoiding trial-and-error practices. This systematic combination of modelling and 
experimentation through process systems engineering tools can, in the future, guide process 
development in the biopharmaceutical industry with an aim to reduce the time required for a 
product to reach the market. 
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NOTATION 
K  heavy- and light-chain mRNA decay rate  (h
-1
) 
KA  assembly rate constant (cell/molecule/h) 
Kd,amm  ammonia constant for cell death (mM) 
Kd,gln  constant for glutamine degradation (h
-1
) 
KER  rate constant for ER-to-Golgi transport (h
-1
) 
KG  rate constants for Golgi-to-medium antibody transport (h
-1
) 
Kglc  Monod constant for glucose (mM) 
Kgln  Monod constant for glutamine (mM) 
KIamm  Monod constant for ammonia (mM) 
KIlac  Monod constant for lactate (mM) 
mglc  maintenance coefficient of glucose (mmol/cell/h) 
NH, NL  heavy- and light-chain gene copy number (gene/cell) 
RH, RL  rates of heavy- and light-chain consumption in assembly (chain/cell/h) 
SH, SL  heavy- and light-chain gene specific transcription rates (mRNA/gene/h) 
TH, TL  heavy- and light-chain specific translation rates (chain/mRNA/h) 
Yamm,gln yield of ammonia from glutamine (mmol/mmol) 
Ylac,glc  yield of lactate from glucose (mmol/mmol) 
Yx,glc  yield of cells on glucose (cell/mmol) 
Yx,gln  yield of cells on glutamine (cell/mmol) 
Greek letters 
1, 2 constants of glutamine maintenance coefficient (mM L/cell/h and mM, 
respectively) 
1  constant for antibody production (h) 
2  constant for antibody production (dimensionless) 
1  ER glycosylation efficiency factor (dimensionless) 
2  Golgi apparatus glycosylation efficiency factor (dimensionless) 
dmax  maximum specific death rate (h
-1
) 
max  maximum specific growth rate (h
-1
) 
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TABLES 
 
Table 1. Parameter values for batch and fed-batch culture operations. 
Parameter Batch operation value Fed-batch operation value 
K (h
-1
) 10
-1
 10
-1
 
KA (cell/molecule-L) 10
-6
 10
-6
 
Kd,amm (mM) 1.76 1.76 
Kd,gln (h
-1
) 9.610-3 9.610-3 
KER (h
-1
) 6.910
-1
 6.910-1 
KG (h
-1
) 1.410
-1
 1.410-1 
Kglc (mM) 7.510
-1
 7.510-1 
Kgln (mM) 7.510
-2
 7.510-2 
KIamm (mM) 28.48 28.48 
KIlac (mM) 171.76 171.76 
Klysis  (h
-1
) 5.510-2 3.010-2 
mglc (mmol/cell-h) 4.910
-14
 4.910-14 
n (-) 2 2 
NH (gene/cell) 1.410
2
 1.0102 
NL (gene/cell) 1.210
2
 1.0102 
SH (mRNA/gene-h) 310
3
 3103 
SL (mRNA/gene-h) 4.510
3
 4.5103 
TH (chain/mRNA-h) 17 17 
TL (chain/mRNA-h) 11.5 11.5 
Yamm,gln (mmol/mmol) 4.310
-1
 4.510-1 
Ylac,glc (mmol/mmol) 1.4 2.0 
Yx,glc  (cell/mmol) 1.110
8
 2.6108 
Yx,gln (cell/mmol) 5.610
8
 8108 
α1 (mM L/cell-h)  3.410
-13
 3.410-13 
α2 (mM) 4 4 
γ1 (-)  10
-1
 10
-1
 
γ2  (h)  2 2 
ε1  (-) 9.910
-1
 9.9510-1 
ε2 (-) 1 1 
μmax (h
-1
)  5.810
-2
 5.810-2 
μd,max (h
-1
) 610-2 610-2 
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 Table 2. Parameter estimation results for fed-batch culture. 
 Confidence Intervals 
Parameter Final value 90% 95% 99% 
Yx,glc 2.610
8
 2.224107 2.654107 3.494107 
Yx,gln 810
8
 2.134107 2.546107 3.352107 
Ylac,glc 2.0 1.76810
-1
 2.10910-1 2.77710-1 
Yamm,gln 4.510
-1
 6.56410-2 7.83210-2 1.03110-1 
Klysis 3.10
-2
 2.52010-3 3.00710-3 3.95910-3 
μmax 5.410
-2
 8.30610-4 9.90910-4 1.30510-3 
NH 101 5.067 6.045 7.959 
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FIGURE LEGENDS 
 
Figure 1. Framework for systematic development of predictive mathematical models for 
animal cell cultures. 
 
Figure 2. Comparison of model results for extracellular MAb concentration (– –) and viable 
cell concentration (―) with experimental data from batch cultures (○ and ●, respectively). 
 
Figure 3. Comparison of model results for glutamine (―) and ammonia concentrations (– –) 
with experimental data from batch cultures (● and ○, respectively). 
 
Figure 4. Comparison of model results for glucose (―) and lactate concentrations (– –) with 
experimental data from batch cultures (● and ○, respectively). 
 
Figure 5. Comparison of model results for viable (―) and total (– –) cell concentrations with 
experimental data from designed fed-batch cultures (● and ○, respectively). 
 
Figure 6. Comparison of model results for glutamine (―) and ammonia (– –) concentrations 
with experimental data from designed fed-batch cultures (● and ○, respectively). 
 
Figure 7. Comparison of model results for extracellular MAb concentration (―) with 
experimental data from designed fed-batch cultures (●). 
 
Figure 8. Comparison of model results for glutamine (―) and ammonia (– –) concentrations 
with experimental data from independent fed-batch cultures (● and ○, respectively). 
 
Figure 9. Comparison of model results for viable (―) and total (– –) cell concentrations with 
experimental data from independent fed-batch cultures (● and ○, respectively). 
 
Figure 10. Comparison of model results for extracellular MAb concentration (―) with 
experimental data from independent fed-batch cultures (●). 
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FIGURES 
 
Figure 1 
 
Step 1 
Model development* 
1. Model structure 
defined based on 
 experimental system 
available for 
validation 
 selected model 
application 
2. Physiological ranges 
for parameter values 
established based on 
literature data 
 
*(Kontoravdi et al., 2005) 
Step 2 
Model analysis 
1. Sensitivity analysis*  
 for qualitative 
assessment of 
‘sensitive’ 
parameters 
 for identification of 
most informative 
sampling times 
Batch experiments for 
providing initial 
parameter estimates
† 
 
*(Kontoravdi et al., 2005) 
†This work 
 
Step 3 
Model validation
† 
1. Optimal design of dynamic 
experiments based on 
 targeting the estimation of 
‘sensitive’ parameters 
 degrees of freedom (feed 
volume and time of addition) 
2. Experimentation 
3. Parameter estimation and 
model validation 
The above steps are repeated until 
model exhibits satisfactory 
agreement with experimental data 
†This work 
Step 4 
Predictive capability
† 
1. Perform an 
independent 
dynamic experiment 
2. Check and confirm 
model validity and 
predictive capability 
by comparing model 
simulation results 
with resulting set of 
data  
 
 
†This work 
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Figure 10 
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Appendix A: List of model equations (Kontoravdi et al., 2005). 
The mass balances on the viable and total cell populations, based on conventional 
assumptions such as perfect mixing and negligible dilution effect, are: 
outin FF
dt
dV
 ,               (1) 
 
voutvdv
v XFVXVX
dt
VXd
  ,             (2) 
 
toutv
t XFVX
dt
VXd
  .                    (3) 
The specific cell growth rate is determined by the concentrations of the glucose, glutamine, 
lactate and ammonia, following Monod kinetics: 
inhff limmax  ,                           (4) 
 
 
 
 

















GLNK
GLN
GLCK
GLC
f
gglc ln
lim
,             (5) 
   

















AMMKI
KI
LACKI
KI
f
amm
amm
lac
lac
inh
.               (6) 
Based on the assumption that cell death only depends on the concentration of ammonia in the 
extracellular medium, the rate of cell death is determined by: 
 
n
ammd
d
d
AMM
K








,
max,
1

 , n>1.              (7) 
The mass balances on glucose and glutamine around the bioreactor are: 
      GLCFGLCFVXQ
dt
GLCVd
outininvglc 
,           (8) 
glc
glcx
glc m
Y
Q 
,

,               (9) 
        GLNFGLNFGLNVKVXQ
dt
GLNVd
outinindgvg  lnln
,         (10) 
ln
ln,
ln g
gx
g m
Y
Q 

,                    (11) 
 
 GLN
GLN
mg


2
1
ln


.                    (12) 
The mass balances for lactate and ammonia are: 
    LACFVXQ
dt
LACVd
outvlac 
,               (13) 
glcglclaclac QYQ , ,               (14) 
      AMMFGLNVKVXQ
dt
AMMVd
outdgvamm  ln
,          (15) 
lnln, ggammamm QYQ  .               (16) 
The heavy- and light-chain mRNA balances are: 
HHH
H KmSN
dt
dm

,              (17) 
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LLL
L KmSN
dt
dm

.               (18) 
The intraER heavy- and light-chain and assembly intermediates balances are: 
 
HHH RmT
dt
Hd

,               (19) 
 
LLL RmT
dt
Ld

,               (20) 
where, 
 2
3
2
HKR AH 
,               (21) 
     LLHKLHKR AAL 222  ,             (22) 
and 
 
    LHKHK
dt
Hd
AA 2
22 2
3
1

,             (23) 
 
     LLHKLHK
dt
LHd
AA 22
2 2
|

.            (24) 
The intraER MAb balance is: 
 
    ERERA
ER LHKLLHK
dt
LHd
222
22

.            (25) 
Similarly, for the Golgi apparatus: 
 
   GGERER
G LHKLHK
dt
LHd
22221
22
 
.                     (26) 
Finally, the rate of MAb production is: 
  
   MAbFVXQ
dt
MAbVd
outvMAb   12
,           (27) 
 GGMAb LHKQ 222 .              (28) 
 
